EKF Diagnostics Holdings Plc - Asset Resilience Ratio
EKF Diagnostics Holdings Plc (EKF) has an Asset Resilience Ratio of -1.58% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital position of EKF Diagnostics Holdings Plc to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2009–2024)
This chart shows how EKF Diagnostics Holdings Plc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see EKF total assets.
Liquid Assets Composition Over Time
This chart breaks down EKF Diagnostics Holdings Plc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore EKF Diagnostics Holdings Plc (EKF) investment intensity to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 0% |
| Short-term Investments | GBX-1.29 Million | -1.58% |
| Total Liquid Assets | GBX-1.29 Million | -1.58% |
Asset Resilience Insights
- Limited Liquidity: EKF Diagnostics Holdings Plc maintains only -1.58% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
EKF Diagnostics Holdings Plc Industry Peers by Asset Resilience Ratio
Compare EKF Diagnostics Holdings Plc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Eurobio Scientific SA
PA:ALERS |
Medical Devices | 10.52% |
|
Profound Medical Corp
TO:PRN |
Medical Devices | 67.66% |
|
EBR Systems Inc
AU:EBR |
Medical Devices | 54.70% |
|
Epitomee Medical Ltd
TA:EPIT |
Medical Devices | 0.24% |
|
Cleo Diagnostics Ltd
AU:COV |
Medical Devices | 94.64% |
|
Aligned Genetics Inc
KQ:238120 |
Medical Devices | 2.22% |
Annual Asset Resilience Ratio for EKF Diagnostics Holdings Plc (2009–2024)
The table below shows the annual Asset Resilience Ratio data for EKF Diagnostics Holdings Plc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | -1.58% | GBX-1.29 Million ≈ $-156.83 |
GBX81.75 Million ≈ $9.95K |
-1.66pp |
| 2011-12-31 | 0.09% | GBX51.00K ≈ $6.21 |
GBX58.73 Million ≈ $7.15K |
-0.19pp |
| 2010-12-31 | 0.28% | GBX100.00K ≈ $12.17 |
GBX35.98 Million ≈ $4.38K |
-7.12pp |
| 2009-12-31 | 7.39% | GBX473.00K ≈ $57.55 |
GBX6.40 Million ≈ $778.33 |
-- |
About EKF Diagnostics Holdings Plc
EKF Diagnostics Holdings plc engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally. The company offers DiaSpect Tm analyzer; Hemo Control, a hemoglobin analyzer; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit rea… Read more